Records
Browse every document routed through Assort Design.
Route Filters
New study uncovers link between pediatric OSA and higher risk of viral infections Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Func
One-line summary: Pediatric obstructive sleep apnea doubles the risk of influenza and COVID-19 infections and persists as a risk marker despite surgical intervention, highlighting the need for targeted preventive strategies.
Citations: 4 · Risk: 1 High / 1 Medium / 0 Low
What are Lipids? Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews Whit
One-line summary: Lipids are diverse hydrocarbon-based molecules essential for energy storage, cell membrane structure, and signaling in living organisms.
Citations: 4 · Risk: 1 High / 1 Medium / 0 Low
Koji Fungus Benefits For Cholesterol, Immunity, And Metabolism Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News He
One-line summary: Koji fungus (Aspergillus oryzae) exhibits promising cholesterol-lowering, immunomodulatory, and metabolic benefits supported by traditional use and emerging clinical and preclinical evidence.
Citations: 4 · Risk: 1 High / 0 Medium / 0 Low
Abacavir/Lamivudine Viatris Drug / Medicine Information Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-
One-line summary: Abacavir/Lamivudine Viatris is a combination antiretroviral therapy used with other agents to slow HIV progression, requiring careful monitoring for hypersensitivity and interactions.
Citations: 1 · Risk: 2 High / 0 Medium / 0 Low
Two new subtypes of MASH revealed with different risks and outcomes Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food Ne
One-line summary: Two new subtypes of metabolic dysfunction-associated steatohepatitis (MASH) with distinct risk profiles and outcomes have been identified, enabling personalized diagnosis and treatment.
Citations: 3 · Risk: 1 High / 0 Medium / 0 Low
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis November 10, 2025
One-line summary: Rezdiffra® (resmetirom) significantly improved liver stiffness, fibrosis biomarkers, portal hypertension risk, and quality of life in patients with compensated MASH cirrhosis over two years, with benefits reversed upon treatment interruption.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low
Rural cancer patients benefit from local surgical care Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z
One-line summary: Rural cancer patients undergoing surgery for colon or lung cancer have similar perioperative outcomes whether treated locally or at distant urban centers, suggesting safe complex surgical care can be provided close to home.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low
Rural cancer patients benefit from local surgical care Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z
One-line summary: Rural cancer patients undergoing colon or lung cancer surgery locally have similar surgical outcomes and mortality rates compared to those traveling to urban centers, suggesting safe, effective care at community hospitals.
Cognitive speed training shows potential to delay dementia for two decades Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional
One-line summary: Cognitive speed training with booster sessions in adults 65+ is linked to a 25% reduced incidence of dementia over 20 years, per NIH-funded ACTIVE trial follow-up.
Home - Madrigal Medical Professionals Contact Us Search for: Back Region United States Germany About Our Leaders Community Corporate Giving Therapeutic Focus What is MASH? Our Medicine Careers & Cultu
One-line summary: Madrigal Pharmaceuticals has developed the first FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH), addressing a critical unmet need in progressive liver disease.